- Cello Group reports a strong performance in the year to the end of December with robust gross profit growth.

Revenue fell to GBP157.3m (2014: GBP169.9m) but gross profit rose by 7.0% to GBP86.7m (2014: GBP81.0m) with like-for-like gross profit growth of 4.2%.

Headline profit before tax rose by 7.1% to £10.0m and headline basic earnings per share increased by 5.8% to 8.61p. Statutory basic earnings per share rose by 31.0% to 3.54p (2014: 2.70p).

Net debt fell to £4.2m, down from £7.2m in 2014 and the full Year dividend is up 10.0% to 2.86p per share (2014: 2.60p).

Chief executive Mark Scott said: "Cello continues to make encouraging progress against its core strategic goals. Cello Health continues to make pleasing progress in building its global footprint whilst maintaining a competitive margin. Signal has largely completed its migration to a unified brand structure, to support its digital proposition, whilst raising its margin. The Group's debt continues to reduce and, as a consequence, the Board continues to raise the dividend significantly. Above all else, the Group continues to invest in organically developing its talented base of outstanding professionals, providing a platform for future growth."

Story provided by